Literature DB >> 23972000

Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling.

Yoshihisa Yamada1, Kiyoshi Suzuma, Michi Ryu, Eiko Tsuiki, Azusa Fujikawa, Takashi Kitaoka.   

Abstract

PURPOSE/AIMS: To evaluate the prognostic factors for the best corrected visual acuity (BCVA) and central subfield macular thickness (CSMT) after vitrectomy with internal limiting membrane (ILM) peeling for diabetic macular edema.
MATERIALS AND METHODS: A total of 44 eyes of 35 patients who had undergone vitrectomy with ILM peeling between March 2008 and September 2009 were examined. The relationships between preoperative systemic or ocular factors and BCVA or CSMT were evaluated before and at 6 months after the surgical procedure.
RESULTS: Mean logarithm of the minimum angle of resolution improved from 0.74 ± 0.35 (mean ± SD) preoperatively to 0.55 ± 0.4 at 6 months postoperatively (p = 0.001). There was a significant improvement of the CSMT from 482 ± 116 μm before the operation to 355 ± 126 μm 6 months after the operation (p < 0.0001). The preoperative CSMT was significantly thicker with ischemic disease (p = 0.0016). Preoperative BCVA was significantly lower when subfoveal hard exudate was present (p = 0.0005). At the 6-month follow-up, CSMT was significantly thicker when there was a higher glycosylated hemoglobin (p = 0.008). BCVA at the 6-month follow-up was significantly lower in the group without any diabetes treatment history (p = 0.0075) prior to the diagnosis of diabetic retinopathy.
CONCLUSIONS: While BCVA and CSMT were associated with ocular factors before surgery, they were associated with glycemic control postoperatively. Glycemic control may be important for retinal thickness after ocular surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23972000     DOI: 10.3109/02713683.2013.820327

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

1.  Single-cell transcriptomic analysis revealing changes in retinal cell subpopulation levels and the pathways involved in diabetic retinopathy.

Authors:  Rui Zhang; Chengyu Huang; Yixuan Chen; Ting Li; Long Pang
Journal:  Ann Transl Med       Date:  2022-05

2.  Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).

Authors:  Young Hee Yoon; David S Boyer; Raj K Maturi; Francesco Bandello; Rubens Belfort; Albert J Augustin; Xiao-Yan Li; Zhanying Bai; Yehia Hashad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-25       Impact factor: 3.117

3.  In Situ Liquid Crystal Gel as a Promising Strategy for Improving Ocular Administration of Dexamethasone: Preparation, Characterization, and Evaluation.

Authors:  Wenqing Wu; Wenxuan Cao; Jingbao Chen; Ye Cai; Baoqi Dong; Xiaoqin Chu
Journal:  AAPS PharmSciTech       Date:  2021-12-23       Impact factor: 3.246

Review 4.  Surgical Versus Medical Treatment for Diabetic Macular Edema: A Review.

Authors:  Nicolás Crim; Raúl Velez-Montoya; Virgilio Morales-Canton
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

Review 5.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04

Review 6.  Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.

Authors:  Shigeo Yoshida; Tomoaki Murakami; Miho Nozaki; Kiyoshi Suzuma; Takayuki Baba; Takao Hirano; Osamu Sawada; Masahiko Sugimoto; Yoshihiro Takamura; Eiko Tsuiki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-30       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.